Working… Menu

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02673008
Recruitment Status : Unknown
Verified January 2016 by Qifa Liu, Nanfang Hospital of Southern Medical University.
Recruitment status was:  Recruiting
First Posted : February 3, 2016
Last Update Posted : October 12, 2017
Guangzhou First People's Hospital
Zhujiang Hospital
Third Affiliated Hospital, Sun Yat-Sen University
Peking University People's Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Information provided by (Responsible Party):
Qifa Liu, Nanfang Hospital of Southern Medical University